Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease

Authors: A Gallardo-Godoy
A Giese
A Giese
A Pfeifer
Andreas A. Deeg
Andrei Leonov
Armin Giese
B Caughey
BS Gadad
C Korth
C Soto
C Wasmer
CA Lipinski
Catharina Prix
CG Glabe
Christian Griesinger
CR Birkett
CR Trevitt
DE Clark
DF Veber
DJ Selkoe
DP Karpinar
E Angot
E Masliah
E Tolosa
F Fornai
F Leidel
F Pan-Montojo
F Pan-Montojo
F Schmidt
Fabienne Leidel
Felix Schmidt
Francisco Pan-Montojo
G Bitan
GB Irvine
Gerda Mitteregger-Kretzschmar
GP Saborio
GR Lamberto
GR Mallucci
HA Lashuel
Hans Kretzschmar
Henning Urlaub
J Bieschke
J Bieschke
J Bieschke
J Castilla
J Collinge
J Collinge
J Safar
J Simon-Sanchez
JD Harper
JD Wadsworth
Jens Pilger
Jens Wagner
Jochen H. Weishaupt
Johannes Levin
JR Cannon
JR Streffer
Julian J. Krauth
Kai Bötzel
KC Luk
L Colombo
M Geissen
M Kostka
M Neumann
Manfred Uhr
Markus Geissen
Markus Zweckstetter
Martin Eiden
Martin Groschup
Mathias Bähr
Matthias Samwer
MH Groschup
MJ Thompson
MS Forman
MS Forman
P Brown
P Desplats
P Mueller
P Weber
Paul Tavan
R Demaimay
S Connelly
S Ghaemmaghami
S Hüls
S Tzaban
SB Prusiner
SB Prusiner
Sergey Ryazanov
Song Shi
T Högen
Thomas Hirschberger
Tobias Frank
U Bertsch
Ulrike Teichmann
Uwe Bertsch
V Gayrard
Wolfgang Zinth
Y Kawasaki
Publication date
Publisher: 'Springer Science and Business Media LLC'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Open in the Core reader

Available Versions

Crossref

redirect

info:doi/10.1007%2Fs00401-013-...

Last time updated on 01/04/2019